Marketing, KSA affiliate, International Operations
As Sr. Manager, Brand Marketing, you will own the integrated brand and portfolio strategy for our diabetes business in Saudi Arabia. You will turn affiliate priorities into clear growth, market-share and return-on-investment objectives, and lead a team that connects strategy, market development and field execution. From launch readiness to new channels and partnerships, your decisions will shape how our treatments reach healthcare professionals and people living with diabetes across KSA.
You are a commercial leader who sets direction, makes clear choices and delivers through others. You will bring:
You will set the strategic direction for the brand and portfolio plan, lead the team that brings it to life, and expand the market, channels and partnerships that drive sustainable growth.
You will join the Marketing team in the KSA affiliate, part of International Operations, where colleagues work across markets to serve people around the world and help improve health at scale. You will report to the Cardiometabolic Associate Director for HCP Marketing
Your closest partners will be Sales, Medical, Market Access & Public Affairs, Finance, Regulatory Affairs, Pharmacovigilance, Procurement and People & Organisation, as well as Business Area and Region leadership. You will represent Commercial Marketing in cross-functional governance, bringing these teams together so decisions are aligned across the product life cycle.
Outside Novo Nordisk, you will build relationships with key and digital opinion leaders, healthcare professionals, scientific societies, hospitals, patient advocacy groups and strategic commercial partners across KSA.
You will be trusted to own decisions. Within agreed objectives and budget governance, you will set direction, allocate resources and approve or recommend priorities and investments – and you will see the results of those choices in the market.
You will work with advanced analytics, market intelligence and AI-enabled tools, and lead experiments with new channels, digital health and omnichannel engagement, scaling what delivers measurable value. Clear performance expectations, honest feedback and a culture that rewards results will support you to grow as a leader while your team grows with you.
Your impact begins today. If you are ready to lead brand strategy that turns insight into progress for people living with diabetes in Saudi Arabia, apply for the Sr. Manager, Brand Marketing role by 21 October 2026.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html